Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
about
Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational sPharmacologic and clinical evaluation of posaconazole.Evaluation of real-life dosing of oral medicines with respect to fluid and food intake in a Dutch-speaking population.Therapeutic drug monitoring of posaconazole oral suspension in paediatric patients younger than 13 years of age: a retrospective analysis and literature review.Preparation and evaluation of posaconazole-loaded enteric microparticles in rats.Posaconazole plasma exposure correlated to intestinal mucositis in allogeneic stem cell transplant patients.An in vitro methodology for forecasting luminal concentrations and precipitation of highly permeable lipophilic weak bases in the fasted upper small intestine.Triazole antifungals used for prophylaxis and treatment of invasive fungal disease in adult haematology patients: Trough serum concentrations in relation to outcome.Posaconazole: An Update of Its Clinical Use.Drug disposition before and after gastric bypass: fenofibrate and posaconazole.Meal Effects Confound Attempts to Counteract Rabeprazole-Induced Hypochlorhydria Decreases in Atazanavir Absorption.Inhibition of antifungal therapy by gastric acid suppressants.Pepsi® or Coke®? Influence of acid on dasatinib absorption.Characteristics of the Human Upper Gastrointestinal Contents in the Fasted State Under Hypo- and A-chlorhydric Gastric Conditions Under Conditions of Typical Drug - Drug Interaction Studies.
P2860
Q34288593-AF1E355A-DAE6-4757-9890-F630A17B75BFQ37445943-44F11791-CD0F-497A-9D89-832EC6D84018Q38815307-9B83A037-AFF5-41C3-9601-64E642F6236FQ39041116-35D9F9D9-B63B-400F-8E23-E00FFE3D7BE6Q39074195-3552DCCA-E24C-4BCD-B265-45F98E15346AQ39553916-BBAACF5D-1CF3-40F1-9118-B9A177E69C30Q39569609-779B499D-A2DD-4DB4-8EB2-87AF1595A633Q40762430-A42B2601-88AC-4841-9A89-C20AD622CE25Q42144246-4AA65356-69F4-4C28-9451-3FFF5901B678Q42700900-3CF09BBC-741D-4F9B-862A-8F3F617E3E80Q46349067-BA73BE57-69E6-46AD-B89C-487ABEA18A71Q46492453-62A7BE81-E007-46A8-A4A1-F49C85DD7E20Q48555829-0EE96CCB-301C-480B-B39E-E66A887A0E28Q50248825-1A94B6EF-7324-4450-811E-CCC49802F34A
P2860
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
description
im November 2011 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 November 2011
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2011
@uk
name
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
@en
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
@nl
type
label
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
@en
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
@nl
prefLabel
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
@en
Effect of pH and Comedication on Gastrointestinal Absorption of Posaconazole
@nl
P2093
P1476
Effect of pH and comedication ...... and plasma drug concentrations
@en
P2093
Isabel Spriet
Jeroen Walravens
Pieter Annaert
P304
P356
10.2165/11592630-000000000-00000
P577
2011-11-01T00:00:00Z
P6179
1013717676